Fennec Pharmaceuticals Inc. (FENC) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Fennec Pharmaceuticals Inc. (FENC) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

FENC Cash Flow Statement

Fennec Pharmaceuticals Inc. (FENC) cash flow statement — 26-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	50K	2.38M	-5.96M	1.49M	-3.69M	-4.32M	-1.47M	-2.21M	-8.39M	39.05M	-4.86M	-2.76M	-3.95M	-5.58M	-6.8M	-5.01M	-3.39M	-2.86M	-3.25M	-2.96M
Operating CF Margin %	0.28%	15.75%	-43.28%	11.98%	-38.19%	-49.34%	-18.6%	-31.63%	-115.49%	153.87%	-49.92%	-42.36%	-118.68%	-332.56%	-443.13%	-	-	-	-	-
Operating CF Growth %	101.36%	155.09%	-304.48%	167.68%	56.05%	-111.06%	69.67%	20.07%	-112.54%	800.14%	28.55%	44.91%	-16.4%	-95.27%	-109.61%	-69.37%	23.41%	20.51%	1.19%	45.68%
Net Income	1.97M	201K	-4.79M	-637K	-3.15M	-1.17M	-1.99M	-5.74M	-5.55M	12.84M	-2.68M	-1.87M	-5.44M	-6.05M	-6.86M	-8.09M	-5.07M	-3.7M	-4.43M	-4.18M
Depreciation & Amortization	25K	26K	1K	51K	25K	39K	121K	46K	49K	743K	0	72K	73K	72K	70K	64K	0	0	0	0
Stock-Based Compensation	1.77M	0	2.52M	2.22M	1.49M	798K	1.12M	1.82M	925K	1.19M	857K	865K	2.54M	1.09M	857K	1.89M	1.01M	399K	910K	917K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-287K	937K	5.56M	-7.42M	1.16M	80K	-1.41M	3.41M	-352K	27.08M	66K	626K	58K	587K	-86K	817K	51K	132K	436K	-31K
Working Capital Changes	-3.44M	1.21M	-9.25M	7.28M	-3.21M	-4.07M	678K	-1.75M	-3.46M	-2.81M	-3.1M	-2.46M	-1.18M	-1.27M	-786K	311K	623K	309K	-164K	341K
Change in Receivables	-4.22M	4.51M	-3.51M	-3.44M	-265K	-5.28M	-175K	-4.2M	-2.04M	-1.46M	-4.29M	-2.08M	-762K	-138K	-1.54M	0	0	0	0	0
Change in Inventory	-518K	-291K	142.45K	624K	-797K	-344K	65K	502K	-80K	92K	-401K	-316K	-521K	-342K	-576K	0	0	0	0	0
Change in Payables	-765K	1.65M	-1.25M	-75K	661K	2.04M	0	0	0	0	837K	0	0	0	0	0	519K	447K	-377K	477K
Cash from Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	1.02M	1.01M	20.8M	1.75M	-284K	359K	-12.21M	-528K	257K	-1.13M	5.73M	201K	514K	193K	824K	19.85M	46K	15K	10K	0
Debt Issued (Net)	0	0	-19.82M	0	0	0	0	0	0	0	5M	0	0	0	173K	0	0	0	0	0
Equity Issued (Net)	1.96M	1.32M	42.99M	-171.41K	-198.47K	369.88K	-9K	-470K	-90K	-19K	0	-14K	-27K	-20K	-28K	-166K	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	-9K	0	-90K	-19K	0	-14K	-27K	-20K	-28K	-166K	0	0	0	0
Other Financing	-941K	-311K	-2.37M	1.92M	-85.53K	-10.88K	-12.2M	-58K	347K	-1.11M	733K	215K	541K	213K	679K	20.01M	46K	15K	10K	0
Net Change in Cash	1.07M	3.39M	14.84M	3.24M	-3.97M	-3.96M	-13.69M	-2.73M	-8.13M	37.91M	870K	-2.56M	-3.43M	-5.38M	-5.98M	14.84M	-3.34M	-2.84M	-3.23M	-2.96M
Free Cash Flow	50K	2.38M	-5.96M	1.49M	-3.69M	-4.32M	-1.47M	-2.21M	-8.39M	39.05M	-4.86M	-2.76M	-3.95M	-5.58M	-6.8M	-5.01M	-3.39M	-2.86M	-3.25M	-2.96M
FCF Margin %	0.28%	15.75%	-43.28%	11.98%	-38.19%	-49.34%	-18.6%	-31.63%	-115.49%	153.87%	-49.92%	-42.36%	-118.68%	-332.56%	-443.13%	-	-	-	-	-
FCF Growth %	101.36%	155.09%	-304.48%	167.68%	56.05%	-111.06%	69.67%	20.07%	-112.54%	800.14%	28.55%	44.91%	-16.4%	-95.27%	-109.61%	-69.37%	23.41%	20.51%	1.19%	45.68%
FCF per Share	0.00	0.07	-0.19	0.05	-0.13	-0.16	-0.05	-0.08	-0.31	1.26	-0.18	-0.10	-0.15	-0.21	-0.26	-0.19	-0.13	-0.11	-0.12	-0.11
FCF Conversion (FCF/Net Income)	0.03x	11.84x	1.25x	-2.34x	1.17x	3.71x	0.74x	0.38x	1.51x	3.04x	1.81x	1.48x	0.72x	0.92x	0.99x	0.62x	0.67x	0.77x	0.73x	0.71x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0